Catalyst Wire Dossier Catalyst Wire Dossier

Bencycloquidium bromide nasal spray

bencycloquidium bromide · Yingu Pharmaceutical Co., Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Bencycloquidium bromide nasal spray, covering 2024-03-04 to 2024-03-04. Get the full timeline:

Most recent: Clinical Trial Update: Study of Bencycloquidium Bromide Nasal Spray in the Treatment of Moderate-severe Persistent Allergic Rhinitis [Phase 4]

See pricing